Microbiome Signatures in Adult Tonsillitis

Background: Adult tonsillitis represents a critically understudied clinical challenge, with treatment protocols primarily derived from pediatric research despite fundamental differences in pathophysiology and antibiotic exposure histories. While Streptococcus species are traditionally considered primary bacterial pathogens, frequent treatment failures with ß-lactam antibiotics suggest unrecognized pathogens may dominate in regions with high antibiotic resistance. We hypothesized that Achromobacter species-opportunistic Gram-negative bacteria with intrinsic multidrug resistance may play a previously unrecognized role in treatment-resistant adult tonsillitis. Methods: We performed culture-independent 16S rRNA gene sequencing and PICRUSt2 functional pathway analysis on tonsillar samples from 90 participants (48 tonsillitis patients, 42 healthy controls; mean age 28.8±16.2 years) from Sargodha region, Pakistan. Clinical metadata including demographics, disease chronicity, and antibiotic exposure, were systematically recorded. Results: Tonsillitis patients demonstrated profound microbiome dysbiosis characterized by unprecedented Achromobacter dominance (53.2% vs. 28.9% in controls, p<0.001, Cohen's d=1.84)—the highest prevalence reported in any tonsillitis cohort globally, exceeding rates in cystic fibrosis populations. Alpha diversity was significantly reduced in both acute (Shannon: 1.89±0.08) and chronic tonsillitis (1.78±0.10) compared to healthy controls (2.63±0.09, p<0.001, ?²=0.68). Principal coordinate analysis revealed distinct clustering explaining 64.3% of variance (PERMANOVA: R²=0.643, p<0.001). Correlation analysis demonstrated coordinated expansion of opportunistic pathogens (Achromobacter-Pseudomonas: r=0.73, p<0.001) with diversity loss (Shannon-Achromobacter: r=-0.68, p<0.001). Functional pathway analysis identified 15 significantly altered pathways (FDR q<10??), including critical upregulation of ABC transporters (2.5-fold), providing molecular explanation for ß-lactam treatment failures. Systemic reprogramming included diabetes mellitus pathways (2.5-fold) and stress response activation (cortisol synthesis: 2.8-fold), indicating impacts beyond local infection. Conclusions: This study reveals Achromobacter as the dominant pathogen in adult tonsillitis for the first time, fundamentally challenging the streptococcal paradigm. The intrinsic resistance profile and coordinated dysbiotic networks provide molecular explanations for frequent treatment failures with standard antibiotics. These findings necessitate immediate revision of diagnostic approaches from culture-dependent to culture-independent methods and suggest targeted therapy with trimethoprim-sulfamethoxazole or carbapenems for treatment-resistant cases. The systemic metabolic implications support comprehensive management approaches addressing both microbial dysbiosis and host inflammatory responses, with global relevance for regions facing similar antibiotic resistance challenges.